Tue, Feb 24, 2026
[Archive]
Articles In Press
Back to the articles list |
Back to browse issues page
Ali Sadighi1 
, Amir Mehdizadeh2 , Mohammad Hossein Somi3 , Sousan Mirnajd Gerami4 , Leila Rahbarnia5 , Mahsa Esmaeillou6 , Suna Kızılyıldırım7 , Ali Bahadori *8
, Amir Mehdizadeh2 , Mohammad Hossein Somi3 , Sousan Mirnajd Gerami4 , Leila Rahbarnia5 , Mahsa Esmaeillou6 , Suna Kızılyıldırım7 , Ali Bahadori *8
1- Liver and gastrointestinal diseases research center, Tabriz University of medical sciences, Tabriz-Iran
2- Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3- Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5- Infectious and tropical disease research center, Tabriz university of Medical Sciences, Tabriz, Iran.
6- Microbiologist, Latis Scientific, London, UK.
7- Süleyman Demirel University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology
8- Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ,Bahadoria@tbzmed.ac.ir
2- Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3- Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5- Infectious and tropical disease research center, Tabriz university of Medical Sciences, Tabriz, Iran.
6- Microbiologist, Latis Scientific, London, UK.
7- Süleyman Demirel University, Faculty of Pharmacy, Department of Pharmaceutical Microbiology
8- Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ,
Abstract: (1 Views)
Background and Objective
Interactions between Helicobacter pylori (H. pylori) and the human host particularly gastric inflammation and cytokine-mediated signaling have been extensively investigated due to their critical role in the pathogenesis of gastric disorders. This study aimed to evaluate the association between IL1B gene polymorphisms and the risk of chronic gastritis and gastric cancer in H. pylori–infected individuals from Northwestern Iran, a region with a considerable burden of gastric disease.
Materials and Methods
A total of 210 participants were enrolled and stratified into three groups: healthy controls, patients with chronic gastritis, and patients with gastric cancer (70 individuals per group). Peripheral blood samples collected in EDTA tubes were used for serological detection of H. pylori using an ELISA assay (Pishtaz Teb diagnostic kit) and for genomic DNA extraction. Genotyping of IL1B polymorphisms at positions −31, −511, and +3954 was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis.
Results
Of the 210 participants, only seven individuals in the gastritis group were positive for H. pylori. The CT genotype of IL1B −31 was more frequently observed in H. pylori–negative patients with gastritis. At the IL1B −511 locus, the CC genotype was significantly more prevalent among H. pylori negative healthy controls, suggesting a protective effect against gastritis (p = 0.023). Additionally, the combined CT+TT genotypes at this locus were significantly associated with gastritis in H. pylori positive individuals (p = 0.010). No significant associations were detected between the IL1B +3954 polymorphism and disease status or H. pylori infection.
Conclusion
These findings demonstrate a significant association between IL1B gene polymorphisms and susceptibility to chronic gastritis and gastric cancer, particularly in the context of H. pylori infection. Further large-scale studies across diverse populations are warranted to elucidate the contribution of host genetic factors to gastric disease risk.
Interactions between Helicobacter pylori (H. pylori) and the human host particularly gastric inflammation and cytokine-mediated signaling have been extensively investigated due to their critical role in the pathogenesis of gastric disorders. This study aimed to evaluate the association between IL1B gene polymorphisms and the risk of chronic gastritis and gastric cancer in H. pylori–infected individuals from Northwestern Iran, a region with a considerable burden of gastric disease.
Materials and Methods
A total of 210 participants were enrolled and stratified into three groups: healthy controls, patients with chronic gastritis, and patients with gastric cancer (70 individuals per group). Peripheral blood samples collected in EDTA tubes were used for serological detection of H. pylori using an ELISA assay (Pishtaz Teb diagnostic kit) and for genomic DNA extraction. Genotyping of IL1B polymorphisms at positions −31, −511, and +3954 was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis.
Results
Of the 210 participants, only seven individuals in the gastritis group were positive for H. pylori. The CT genotype of IL1B −31 was more frequently observed in H. pylori–negative patients with gastritis. At the IL1B −511 locus, the CC genotype was significantly more prevalent among H. pylori negative healthy controls, suggesting a protective effect against gastritis (p = 0.023). Additionally, the combined CT+TT genotypes at this locus were significantly associated with gastritis in H. pylori positive individuals (p = 0.010). No significant associations were detected between the IL1B +3954 polymorphism and disease status or H. pylori infection.
Conclusion
These findings demonstrate a significant association between IL1B gene polymorphisms and susceptibility to chronic gastritis and gastric cancer, particularly in the context of H. pylori infection. Further large-scale studies across diverse populations are warranted to elucidate the contribution of host genetic factors to gastric disease risk.
Type of Study: Original Research Article |
Subject:
Medical Biology
Received: 2025/04/15 | Accepted: 2026/02/24
Received: 2025/04/15 | Accepted: 2026/02/24
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Journal of Advances in Medical and Biomedical Research by Farname Inc. is licensed under CC BY-NC 4.0
